Fennec Pharmaceuticals Inc (FENC)

Deferred Revenue

$3.18M

Quarterly · Period ending: · USD

FENC logo

FENC Deferred Revenue

Latest reported$3.18M
FENC Quarterly Deferred Revenue ($0.00 → $3.18M)
High-resolution chart · PNG

FENC deferred revenue history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Fennec Pharmaceuticals Inc Deferred Revenue — Quarterly (USD)
Period endingDeferred Revenue (USD)
3,182,000
248,000
248,000
248,000
248,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.